Clinical and Histopathological Characteristics of Patients With Myocarditis After mRNA COVID-19 Vaccination.
Omori T, Maruyama K, Ohta-Ogo K, Hatakeyama K, Ishibashi-Ueda H, Onoue K, Nagai T, Kato S, Okumura T, Oikawa M, Amiya E, Yoshizawa S, Suzuki T, Goto H, Nakamura K, Fujino T, Moriwaki K, Nakamori S, Anzai T, Sakata Y, Hiroe M, Imanaka-Yoshida K, Dohi K; Comprehensive Biopsy Features and Outcomes in Myocarditis After COVID-19 mRNA Vaccination (COMBAT COVID-19) Study Investigators.
Omori T, et al. Among authors: ohta ogo k.
Circ J. 2024 Nov 1. doi: 10.1253/circj.CJ-24-0506. Online ahead of print.
Circ J. 2024.
PMID: 39496392